238 related articles for article (PubMed ID: 17674979)
1. How much radiation is the chemotherapy worth in advanced head and neck cancer?
Kasibhatla M; Kirkpatrick JP; Brizel DM
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1491-5. PubMed ID: 17674979
[TBL] [Abstract][Full Text] [Related]
2. Mucositis versus tumor control: the therapeutic index of adding chemotherapy to irradiation of head and neck cancer.
Lee IH; Eisbruch A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1060-3. PubMed ID: 19304406
[TBL] [Abstract][Full Text] [Related]
3. Radiation Therapy Oncology Group (RTOG) studies in head and neck cancer.
Marcial VA; Pajak TF; Kramer S; Davis LW; Stetz J; Laramore GE; Jacobs JR; Al-Sarraf M; Brady LW
Semin Oncol; 1988 Feb; 15(1):39-60. PubMed ID: 3278390
[TBL] [Abstract][Full Text] [Related]
4. Use of concept of chemotherapy-equivalent biologically effective dose to provide quantitative evaluation of contribution of chemotherapy to local tumor control in chemoradiotherapy cervical cancer trials.
Plataniotis GA; Dale RG
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1538-43. PubMed ID: 18786779
[TBL] [Abstract][Full Text] [Related]
5. Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.
Nuyts S; Dirix P; Clement PM; Poorten VV; Delaere P; Schoenaers J; Hermans R; Van den Bogaert W
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1088-95. PubMed ID: 18707823
[TBL] [Abstract][Full Text] [Related]
6. Correction to Kasibhatla et al. How much radiation is the chemotherapy worth in advanced head and neck cancer? (Int j radiat oncol biol phys 2007;68:1491-1495).
Fowler JF
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):326-9. PubMed ID: 18474309
[TBL] [Abstract][Full Text] [Related]
7. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
8. Chemoradiotherapy: emerging treatment improvement strategies.
Milas L; Mason KA; Liao Z; Ang KK
Head Neck; 2003 Feb; 25(2):152-67. PubMed ID: 12509799
[TBL] [Abstract][Full Text] [Related]
9. Chemoradiotherapy with carboplatin in continuous infusion in the locoregional control of advanced head and neck cancer.
Marmiroli L; Nardone L; Salvi G; Ziccarelli P; Fiorentino G; Ausili-Cèfaro G
Rays; 1998; 23(3):549-54. PubMed ID: 9932473
[TBL] [Abstract][Full Text] [Related]
10. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
[TBL] [Abstract][Full Text] [Related]
11. Frequency of esophageal stenosis after simultaneous modulated accelerated radiation therapy and chemotherapy for head and neck cancer.
Lawson JD; Otto K; Grist W; Johnstone PA
Am J Otolaryngol; 2008; 29(1):13-9. PubMed ID: 18061826
[TBL] [Abstract][Full Text] [Related]
12. The chemoradiation paradigm in head and neck cancer.
Seiwert TY; Salama JK; Vokes EE
Nat Clin Pract Oncol; 2007 Mar; 4(3):156-71. PubMed ID: 17327856
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity analysis of parameters in linear-quadratic radiobiologic modeling.
Fowler JF
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1532-7. PubMed ID: 19306749
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.
Langer CJ; Harris J; Horwitz EM; Nicolaou N; Kies M; Curran W; Wong S; Ang K
J Clin Oncol; 2007 Oct; 25(30):4800-5. PubMed ID: 17947728
[TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
[TBL] [Abstract][Full Text] [Related]
17. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer.
Rengan R; Pfister DG; Lee NY; Kraus DH; Shah JP; Shaha AR; Ben-Porat LS; Zelefsky MJ
Am J Clin Oncol; 2008 Oct; 31(5):465-9. PubMed ID: 18838883
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis.
Siddiqui F; Pajak TF; Watkins-Bruner D; Konski AA; Coyne JC; Gwede CK; Garden AS; Spencer SA; Jones C; Movsas B
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):353-60. PubMed ID: 17889449
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).
Machtay M; Pajak TF; Suntharalingam M; Shenouda G; Hershock D; Stripp DC; Cmelak AJ; Schulsinger A; Fu KK;
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1008-17. PubMed ID: 17716826
[TBL] [Abstract][Full Text] [Related]
20. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck.
Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J
Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
